"Our mission is to change the landscape of Substance Abuse testing,
by merging science and social responsibility."
by merging science and social responsibility."
Drug Information

The first step in controling drug or alcohol use in the work place, is learning how to recognize the signs and symptoms of the employee who is abusing them.
Drug use in the workplace
Nearly 75 percent of all adult illicit drug users are employed, as are most binge and heavy alcohol users. Studies show that when compared with non–substance abusers, substance-abusing employees are more likely to:-
• change jobs frequently
• be late to or absent from work
• be less productive employees • be involved in a workplace accident
• file a workers’ compensation claim.
Benefits to having drug-free workplace programs
- Employers with successful drug-free workplace programs report improvements in morale and productivity, and decreases in absenteeism, accidents, downtime, turnover, and theft.
- Employers with longstanding programs report better health status among employees and family members and decreased use of medical benefits by these same groups.
- Some organizations with drug-free workplace programs qualify for incentives, such as decreased costs for workers’ compensation and other kinds of insurance.
Specific Drug Types
| Alcohol | Amphetamines | Anabolic Steroids | ||
| Barbiturates | Benzodiazepines | Cocaine | ||
| Ketamine | LSD | Marijuana | ||
| Methaqualone | Opiates | Phencyclidine (PCP) | ||
| Propoxyphene | Rohypnol | MDMA |
Common Drugs of use A-Z
Depressants (Downers)
| Proprietary Name | Substance Type | DEA Schedule* |
| Beer, Wine, Liquor | Alcohol | Not Scheduled |
| Amytal | Barbiturate | II |
| Nembutal | Barbiturate | II |
| Phenobarbital | Barbiturate | IV |
| Seconal | Barbiturate | II |
| Ativan | Benzodiazepine | IV |
| Halcion | Benzodiazepine | IV |
| Librium | Benzodiazepine | IV |
| Rohypnol | Benzodiazepine | IV |
| Valium | Benzodiazepine | IV |
| Xanax | Benzodiazepine | IV |
Stimulants (Uppers)
| Proprietary Name | Substance Type | DEA Schedule* |
| Ritalin | Methyl- phenidate | II |
| Adderall | Amphetamine | II |
| Biphetamine | Amphetamine | II |
| Crystal Meth | Methamphetamine | II |
| Dexedrine | Amphetamine | II |
| Coke, Crack, Blow | Cocaine | II |
Opioids and Morphine Derivatives (Pain Killers)
| Proprietary Name | Substance Type | DEA Schedule* |
| Dilaudid | Opiate | II |
| Fentanyl | Opiate | I |
| Heroin | Opiate | I |
| Lorcet | Opiate | II |
| Lortab | Opiate | II |
| Methadone | Opiate | I |
| Morphine | Opiate | I |
| OxyContin | Opiate | II |
| Percocet | Opiate | II |
| Percodan | Opiate | II |
| Tylox | Opiate | II |
| Vicodin | Opiate | II |
*Drug Enforcement Administration (DEA) Schedule I and II drugs have a high potential for abuse. They require greater storage security and have a quota on manufacture among other restrictions. Schedule I drugs are available for research only and have no approved medical use. Schedule II drugs are available only through prescription, cannot have refills and require a form for ordering. Schedule III and IV drugs are available with prescription, may have 5 refills in 6 months and may be ordered orally. Most Schedule V drugs are available over the counter.
Testing & Collection
Background Checks
Policy Development
Program Management
Medical Review
Training
DNA Testing- -Contact Email
- -General Inquiries
All Services:
Contact Info:
